Medical oncologists Dr. Priya Vishnubhotla, Dr. Sabarish Ram Ayyappan and Dr. Dhivya Prabhakar, alongside thoracic surgeon Dr. Jason Budde, mark the latest additions to City of Hope Atlanta’s physician team.
These board-certified, fellowship-trained physicians will help expand the hospital’s disease-specific cancer centers while laying the foundation for a focused hematologic malignancy program, including bone marrow and blood stem cell transplant (BMT) capabilities.
Priya Vishnubhotla, MD
Medical oncologist Dr. Priya Vishnubhotla joins City of Hope as the chief of medical oncology with clinical expertise in breast cancer, hematologic malignancies, antibody-drug conjugates and clinical research. She brings nearly two decades of experience as a hematologist/oncologist to City of Hope Atlanta, including nearly a decade in clinical leadership at the Orlando Veterans Administration Healthcare System.
Sabarish Ram Ayyappan, MD
Hematologic oncologist Dr. Sabarish Ram Ayyappan will serve as the medical director of hematologic malignancies. He has amassed almost a decade of experience in hematology and oncology and holds a strong passion for clinical research studies. Dr. Ayyappan previously served as assistant professor at University of Iowa’s Division of Hematology, Oncology and Blood and Marrow Transplantation.
Dhivya Prabhakar, MD
Triple board certified in internal medicine, hematology and oncology, Dr. Dhivya Prabhakar joins the medical oncology roster to focus on genitourinary, breast and neuroendocrine tumors. She is well-published in oncology studies on triple-negative breast cancer, lymphoma and multiple myeloma. Dr. Prabhakar’s past experience includes serving as assistant professor to University of Iowa’s Division of Hematology, Oncology and Blood and Marrow Transplantation and as attending physician at the Iowa City Veterans Affairs Clinic.
Jason Budde, MD
With almost 16 years of combined oncology and surgery experience under his belt, including clinical leadership, education and research, Dr. Jason Budde joins the medical staff as a thoracic surgeon, concentrating on the evaluation and treatment of patients with cancers in the chest area, most frequently those diagnosed with lung or esophageal cancer. Dr. Budde will be a key player in the hospital’s Lung Cancer Center. Previously, he held a cardiothoracic surgeon position at Northeast Georgia Health Systems.
